Xixi YANG, Qingwei CHEN, Liwen YE, et al. MiRNA-145 inhibits proliferation and angiogenesis of endothelial cells by targeting inhibition of cAMP-responsive element-binding protein in vitro[J]. Journal of Third Military Medical University, 2018, 40(13): 1213-1220.
DOI:
Xixi YANG, Qingwei CHEN, Liwen YE, et al. MiRNA-145 inhibits proliferation and angiogenesis of endothelial cells by targeting inhibition of cAMP-responsive element-binding protein in vitro[J]. Journal of Third Military Medical University, 2018, 40(13): 1213-1220. DOI: 10.16016/j.1000-5404.201712004.
MiRNA-145 inhibits proliferation and angiogenesis of endothelial cells by targeting inhibition of cAMP-responsive element-binding protein in vitro
To construct recombinant adenoviruses of microRNA-145 (miRNA-145) stable expression and interference
and to investigate their effects and the underlying mechanism on the proliferation and angiogenesis of endothelial cells.
Methods
2
The shuttle plasmid of pHBAd-EF1-MCS-GFP and pHBAd-U6-CMV-GFP were used to construct miR-145 overexpression and interference adenoviruses with the aid of T
4
ligase. After packaged with backbone plasmid pHBAd-BHG and amplified in HEK293 cells
the infection titers of the viruses were detected by TCID50 assay. The vectors were used to infect human umbilical vein endothelial cells (HUVECs)
and then the miRNA-145 level was detected by qRT-PCR
cell proliferation was evaluated by MTT assay and the expression level of proliferating cell nuclear antigen (PCNA) was detected by Western blotting. Angiogenesis was assessed by tube formation assay. Target genes and interaction between miR-145 and cAMP-responsive element binding protein (CREB) were predicted by bioinformatics software
miRanda and miRwalk. Then CREB and VEGF proteins after virus transfection were determined by Western blotting. And the binding site of miR-145 to CREB 3′UTR was examined by Luciferase reporter assay.
Results
2
Gene sequencing verified that the motifs of miRNA-145 overexpression and interference plasmids were in accordance with target sequences
and the results of qRT-PCR indicated the successful construction of the vectors. In cell proliferation and angiogenesis assays
0.05). MiRNA-145 overexpression inhibited the expression of CREB and VEGF proteins (
P
<
0.05)
whereas
the interference up-regulated both of them (
P
<
0.05). Luciferase reporter a
ssay showed miR-145 directly bound to CREB 3′UTR.
Conclusion
2
miRNA-145 regulates the proliferation and angiogenesis of endothelial cells
which is associated with its inhibition to CREB/VEGF signaling.
关键词
Keywords
references
KEELEY E C, BOURA J A, GRINES C L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials[J]. Lancet, 2006, 367(9510): 579-588. DOI:10.1016/S0140-6736(06)68148-8.
VAN DER LAAN A M, PIEK J J, VAN ROYEN N. Targeting angiogenesis to restore the microcirculation after reperfused MI[J]. Nat Rev Cardiol, 2009, 6(8):515-523. DOI:10.1038/nrcardio.2009.103.
COCHAIN C, CHANNON K M, SILVESTRE J S. Angiogenesis in the infarcted myocardium[J]. Antioxid Redox Signal, 2013, 18(9): 1100-1113. DOI:10.1089/ars.2012.4849.
KAN X, WU Y, MA Y, et al. Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis[J]. Cardiovasc Res, 2016, 109(2): 249-259. DOI:10.1093/cvr/cvv255.
WELTEN S M, GOOSSENS E A, QUAX P H, et al. The multifactorial nature of microRNAs in vascular remodelling[J]. Cardiovasc Res, 2016, 110(1):6-22. DOI:10.1093/cvr/cvw039.
GOU L, ZHAO L, SONG W, et al. Inhibition of miR-92a suppresses oxidative stress and improves endothelial function by upregulating heme oxygenase-1 in db/db mice[J]. Antioxid Redox Signal, 2018, 28(5):358-370. DOI:10.1089/ars.2017.7005.
KASSAN M, VIKRAM A, LI Q, et al. MicroRNA-204 promotes vascular endoplasmic reticulum stress and endothelial dysfunction by targeting Sirtuin1[J]. Sci Rep, 2017, 7(1):9308. DOI:10.1038/s41598-017-06721-y.
CHENG Y, LIU X, YANG J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation[J]. Circ Res, 2009, 105(2):158-166. DOI:10.1161/CIRCRESAHA.109.197517.
CLIMENT M, QUINTAVALLE M, MIRAGOLI M, et al. TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization[J]. Circ Res, 2015, 116(11):1753-1764. DOI:10.1161/CIRCRESAHA.116.305178.
CORDES K R, SHEEHY N T, WHITE M P, et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity[J]. Nature, 2009, 460(7256): 705-710. DOI:10.1038/nature08195.
HERGENREIDER E, HEYDT S, TREQUER K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs[J]. Nat Cell Biol, 2012, 14(3): 249-256. DOI:10.1038/ncb2441.
LOVREN F, PAN Y, QUAN A, et al. MicroRNA-145 targeted therapy reduces atherosclerosis[J]. Circulation, 2012, 126(11 Suppl 1): S81-S90. DOI:10.1161/CIRCULATIONAHA.111.084186.
MARZI A, FELDMANN F, HANLEY P W, et al. Delayed disease progression in Cynomolgus Macaques infected with Ebola Virus Makona Strain[J]. Emerg Infect Dis, 2015, 21(10): 1777-1783. DOI:10.3201/eid2110.150259.
O'SULLIVAN J F, MARTIN K, CAPLICE N M. Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam" [J]. J Am Coll Cardiol, 2011, 57(4): 383-389. DOI:10.1016/j.jacc.2010.09.029.
DONG Y M, LIU X X, WEI G Q, et al. Prediction of long-term outcome after acute myocardial infarction using circulating miR-145[J]. Scand J Clin Lab Invest, 2015, 75(1): 85-91. DOI:10.3109/00365513.2014.981855.
FRIEDMAN R C, FARH K K, BURGE C B, et al. Most mammalian mRNAs are conserved targets of microRNAs[J]. Genome Res, 2009, 19(1):92-105. DOI:10.1101/gr.082701.108.
ZHANG C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease[J]. Cell Cycle, 2009, 8(21):3469-3473. DOI:10.4161/cc.8.21.9837.
HIGASHI K, YAMADA Y, MINATOGUCHI S, et al. MicroRNA-145 repairs infarcted myocardium by accelerating cardiomyocyte autophagy[J]. Am J Physiol Heart Circ Physiol, 2015, 309(11): H1813-H1826. DOI:10.1152/ajpheart.00709.2014.
ORR A W, HASTINGSN E, BLACKMAN B R, et al. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis[J]. J Vasc Res, 2010, 47(2): 168-180. DOI:10.1159/000250095.
WU D, ZHAU H E, HUANG W C, et al. cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis[J]. Oncogene, 2007, 26(35): 5070-5077. DOI:10.1038/sj.onc.1210316.
SHNEOR D, FOLBERG R, PEER J, et al. Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma[J]. Cancer Gene Ther, 2017, 24(2): 64-74. DOI:10.1038/cgt.2016.68.
RHEE S H, MA E L, LEE Y, et al. Corticotropin releasing hormone and Urocortin 3 stimulate vascular endothelial growth factor expression through thecAMP/CREB pathway[J]. J Biol Chem, 2015, 290(43): 26194-26203. DOI:10.1074/jbc.M115.678979.
KANG Z, ZHU H, LUAN H, et al. Curculigoside A induces angiogenesis through VCAM-1/Egr-3/CREB/VEGF signaling pathway[J]. Neuroscience, 2014, 267: 232-240. DOI:10.1016/j.neuroscience.2014.02.050.
TAN X, WANG S, YANG B, et al. The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells[J]. PLoS ONE, 2012, 7(11): e49570. DOI:10.1371/journal.pone.0049570.
TAN X, WANG S, ZHU L, et al. cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a[J]. Proc Natl Acad Sci U S A, 2012, 109(39): 15805-15810. DOI:10.1073/pnas.1207787109.
ZHANG J Q, YAO Q H, KUANG Y Q, et al. Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma[J]. Hum Pathol, 2014, 45(10):2154-2161. DOI:10.1016/j.humpath.2014.01.025.